Latest filing published 23 Apr 2018 for Surface Oncology, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +4.3%Entry US$11.74 · Close at T+365 US$12.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
LV Management Group, LLC: trading record in brief
LV Management Group, LLC is a declared insider at 3 companies; the most frequent names are Protagonist Therapeutics, Inc, Rein Therapeutics, Inc. and Surface Oncology, Inc. In total, 8 filings cover trades dated from 16 August 2016 to 23 April 2018.
No open-market sale appears; the market trades are 3 purchases worth €12.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2018 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €3.3M.
On 23 April 2018 came the latest disclosure, a transaction in Surface Oncology, Inc. The most recent open-market purchase was published on 23 April 2018, 3,122 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to LV Management Group, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,181,817 sharesCommon StockSEC:0001209191-18-025824:0
- 266,000 shares@ US$15.00100.0% of flowCommon StockSEC:0001209191-18-025824:1Canonical exit: 22 Jul 2018 (T+90)
- 844,987 sharesCommon StockSEC:0000899243-17-018092:0
- 250,000 shares@ US$15.00Common StockSEC:0000899243-17-018092:1Canonical exit: 3 Oct 2017 (T+90)
- 206,896 sharesCommon StockSEC:0001209191-16-137314:0
- 630,541 sharesCommon StockSEC:0001209191-16-137314:1
- 678,712 sharesCommon StockSEC:0001209191-16-137314:2
- 583,333 shares@ US$12.00100.0% of flowCommon StockSEC:0001209191-16-137314:3Canonical exit: 14 Nov 2016 (T+90)
8 of 8 declarations
